LONG-TERM TREATMENT OF DOUBLE DEPRESSION - A PRELIMINARY-STUDY WITH SEROTONERGIC ANTIDEPRESSANTS

被引:19
作者
HELLERSTEIN, DJ
YANOWITCH, P
ROSENTHAL, J
HEMLOCK, C
KASCH, K
SAMSTAG, LW
WINSTON, A
机构
[1] BETH ISRAEL MED CTR, MOOD DISORDERS RES UNIT, NEW YORK, NY USA
[2] MT SINAI SCH MED, DEPT PSYCHIAT, NEW YORK, NY USA
关键词
DOUBLE DEPRESSION; DYSTHYMIA; MAJOR DEPRESSION; FLUOXETINE; TRAZODONE;
D O I
10.1016/0278-5846(94)90030-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Hellerstein, David J., Philip Yanowitch, Jesse Rosenthal, Camille Hemlock, Karen Kasch, Lisa Samstag and Arnold Winston: Long-Term Treatment of Double Depression: A Preliminary Study with Serotonergic Antidepressants. Prog. Neuro-Psychopharmacol. and Biol. Psychiat. 1994, 18(1) : 139-147. 1. There is increasing evidence that many patients with major depression also have coexisting dysthymia, and that antidepressant treatment may alleviate both conditions. 2. Open-label study of fluoxetine and trazodone for 18 patients meeting DSM-III-R criteria for concurrent dysthymia and major depression. 3. Fourteen patients completed three-month medication trials, and seven (50%) of completers) responded to treatment. At five months, eight (57.1%) were in remission. Fluoxetine was significantly better tolerated than trazodone, with respective dropout rates of 7.7% and 80%. 4. Findings are consistent with efficacy of serotonergic agents in this condition.
引用
收藏
页码:139 / 147
页数:9
相关论文
共 50 条
  • [41] Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression
    Wagner, Gerd
    Koch, Kathrin
    Schachtzabel, Claudia
    Sobanski, Thomas
    Reichenbach, Juergen R.
    Sauer, Heinrich
    Schloesser, Ralf G. M.
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2010, 35 (04): : 247 - 257
  • [42] Long-Term Prognosis of Patients with Major Depression and Silent Cerebral Infarction
    Yamashita, H.
    Fujikawa, T.
    Takami, H.
    Yanai, I.
    Okamoto, Y.
    Morinobu, S.
    Yamawaki, S.
    NEUROPSYCHOBIOLOGY, 2010, 62 (03) : 177 - 181
  • [43] Depression Effects on Long-term Prescription Opioid Use, Abuse, and Addiction
    Sullivan, Mark D.
    CLINICAL JOURNAL OF PAIN, 2018, 34 (09) : 878 - 884
  • [44] Prevention of Depression in At-Risk Adolescents: Moderators of Long-term Response
    Garber, J.
    Weersing, V. R.
    Hollon, S. D.
    Porta, G.
    Clarke, G. N.
    Dickerson, J. F.
    Beardslee, W. R.
    Lynch, F. L.
    Gladstone, T. G.
    Shamseddeen, W.
    Brent, D. A.
    PREVENTION SCIENCE, 2018, 19 (01) : S6 - S15
  • [45] Long-term efficacy and therapeutic drug monitoring of sertraline in major depression
    Mauri, MC
    Fiorentini, A
    Cerveri, G
    Volonteri, LS
    Regispani, F
    Malvini, L
    Boscati, L
    Lo Baido, R
    Invernizzi, G
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2003, 18 (05) : 385 - 388
  • [46] Decrease of the platelet 5-HT2A receptor function by long-term imipramine treatment in endogenous depression
    Gómez-Gil, E
    Gastó, C
    Carretero, M
    Díaz-Ricart, M
    Salamero, M
    Navinés, R
    Escolar, G
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2004, 19 (04) : 251 - 258
  • [47] Changing the Paradigm in Treatment-Resistant Depression: A Review of Long-Term Efficacy and Tolerability of Esketamine Nasal Spray
    Herrera-Imbroda, Jesus
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2023, 31 (06) : 1092 - 1101
  • [48] A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial
    Larisa Duffy
    Faye Bacon
    Caroline S. Clarke
    Yvonne Donkor
    Nick Freemantle
    Simon Gilbody
    Rachael Hunter
    Tony Kendrick
    David Kessler
    Michael King
    Paul Lanham
    Gemma Lewis
    Dee Mangin
    Louise Marston
    Michael Moore
    Irwin Nazareth
    Nicola Wiles
    Glyn Lewis
    Trials, 20
  • [49] A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial
    Duffy, Larisa
    Bacon, Faye
    Clarke, Caroline S.
    Donkor, Yvonne
    Freemantle, Nick
    Gilbody, Simon
    Hunter, Rachael
    Kendrick, Tony
    Kessler, David
    King, Michael
    Lanham, Paul
    Lewis, Gemma
    Mangin, Dee
    Marston, Louise
    Moore, Michael
    Nazareth, Irwin
    Wiles, Nicola
    Lewis, Glyn
    TRIALS, 2019, 20 (1)
  • [50] Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer
    Bates, Nicole
    Bello, Jennifer K.
    Osazuwa-Peters, Nosayaba
    Sullivan, Mark D.
    Scherrer, Jeffrey F.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (03) : 348 - 358